Hellerstein, David J.

Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

Goodwin, G. M., Aaronson, S. T., Alvarez, O., Arden, P. C., Baker, A., Bennett, J. C., Bird, C., Blom, R. E., Brennan, C., Brusch, D., et al. (2022) · New England Journal of Medicine

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 1,167

Antidepressants Normalize the Default Mode Network in Patients With Dysthymia

Posner, J., Hellerstein, D. J., Gat, I., Mechling, A., Klahr, K., Wang, Z., McGrath, P. J., Stewart, J. W., & Peterson, B. S. (2013) · JAMA Psychiatry

Functional Brain Connectivity StudiesTreatment of Major Depression

Cited by 268

Neurocognitive predictors of antidepressant clinical response

Bruder, G. E., Alvarenga, J. E., Alschuler, D., Abraham, K., Keilp, J. G., Hellerstein, D. J., Stewart, J. W., & McGrath, P. J. (2014) · Journal of Affective Disorders

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 89

Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research

Bender, D., & Hellerstein, D. J. (2022) · Psychopharmacology

Psychedelics and Drug StudiesReligion, Spirituality, and Psychology

Cited by 88

Pilot study of single-dose psilocybin for serotonin reuptake inhibitor-resistant body dysmorphic disorder

Schneier, F. R., Feusner, J., Wheaton, M. G., Gomez, G. J., Cornejo, G., Naraindas, A. M., & Hellerstein, D. J. (2023) · Journal of Psychiatric Research

Body Image and Dysmorphia StudiesPsychedelics and Drug Studies

Cited by 81

A randomized trial of interpersonal psychotherapy, problem solving therapy, and supportive therapy for major depressive disorder in women with breast cancer

Blanco, C., Markowitz, J. C., Hellerstein, D. J., Nezu, A. M., Wall, M., Olfson, M., Chen, Y., Levenson, J., Onishi, M., Varona, C., et al. (2019) · Breast Cancer Research and Treatment

Cancer survivorship and carePsychotherapy Techniques and Applications

Cited by 59

The association between antidepressant treatment and brain connectivity in two double-blind, placebo-controlled clinical trials: a treatment mechanism study

Wang, Y., Bernanke, J., Peterson, B. S., McGrath, P., Stewart, J., Chen, Y., Lee, S., Wall, M., Bastidas, V., Hong, S., et al. (2019) · The Lancet Psychiatry

Treatment of Major DepressionFunctional Brain Connectivity Studies

Cited by 55

Evidence for neuroplastic compensation in the cerebral cortex of persons with depressive illness

Bansal, R., Hellerstein, D. J., & Peterson, B. S. (2018) · Molecular Psychiatry

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 41

Early augmentation of sertraline with methylphenidate

Postolache, T. T., Rosenthal, R. N., Hellerstein, D. J., Aromin, R., Kelton, G. M., Muran, J. C., & Londono, J. H. (1999) · The Journal of Clinical Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 26

A randomized, controlled trial assessing the acute efficacy of triple chronotherapy in unipolar depression

Yuen, L. D., Chen, Y., Stewart, J. W., Arden, P., & Hellerstein, D. J. (2021) · Journal of Affective Disorders

Treatment of Major DepressionCircadian rhythm and melatonin

Cited by 12

Effects of the antidepressant medication duloxetine on brain metabolites in persistent depressive disorder: A randomized, controlled trial

Bansal, R., Hellerstein, D. J., Sawardekar, S., O’Neill, J., & Peterson, B. S. (2019) · PLOS ONE

Treatment of Major DepressionAdvanced MRI Techniques and Applications

Cited by 8